Prometheus Bio Inc.

medical devices

About

Located in Hangzhou, China, Prometheus is committed to a true partnership with customers by providing fast, high-quality and accurate diagnostics products and services. Prometheus is owned by CPC Group, which is a global leader in peptide industry. Focusing on technology, innovation and quality control, our manufacturing covers a broad range of areas: Drug Test Series; Women's Health Series; Cardiac Markers Series; Infectious Diseases Series and Tumor Markers Series. Due to strict quality standards, outstanding product design and one-stop shop services, Prometheus is currently the preferred vendor for many customers at home and overseas. Prometheus' plant was granted ISO 9001:2008 & ISO13485:2003 certification. In November 2012, Prometheus' production facility was inspected by US FDA and no 483 form was issued. High standards and compliance, to which Prometheus faithfully adheres, allowing our customers to have the utmost confidence in the validity of their project.

Technologies

Mobile Friendly AddThis Google Font API Apache

Keywords

in vitro diagnostics drug of abuse cardiac markers womens health tumor markers infectious diseases medical equipment manufacturing rapid diagnostic tests infectious disease diagnostics drug of abuse tests poct platforms automated test devices point of care testing diagnostic platforms drug screening saliva drug tests immunofluorescence platform b2b fecal occult blood tests fluorescence immunity urine drug tests ce marked tests healthcare government infectious disease tests fda approved feline and canine rapid tests monkeypox virus tests kidney function tests vector borne pathogens

Location

Hangzhou, China, 310018

Related Companies

Companies in the same industry